Review




Structured Review

Novavax Inc proprietary adjuvant matrix m
Proprietary Adjuvant Matrix M, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+adjuvant+matrix-m/adjuvant+m+matrix/pm35542043-441-19-18
Average 86 stars, based on 1 article reviews
proprietary adjuvant matrix m - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

other:

Article Title: Human Vaccines & Immunotherapeutics: News
Article Snippet: The clinical-stage biopharmaceutical company Novavax Inc., recently announced positive results from a Phase 1/2 clinical trial of its H7N9 avian influenza virus-like particle vaccine candidate (H7N9 VLP) formulated with their proprietary adjuvant Matrix-M. Novavax focuses on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.



Similar Products

86
Novavax Inc proprietary adjuvant matrix m
Proprietary Adjuvant Matrix M, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+adjuvant+matrix-m/adjuvant+m+matrix/pm35542043-441-19-18
Average 86 stars, based on 1 article reviews
proprietary adjuvant matrix m - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Novavax Inc the company’s proprietary saponin-based matrix-m™ adjuvant
The Company’s Proprietary Saponin Based Matrix M™ Adjuvant, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+adjuvant+matrix-m/saponin+based+matrix+mtm+adjuvant/pmc08442988-239-26-17
Average 90 stars, based on 1 article reviews
the company’s proprietary saponin-based matrix-m™ adjuvant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Novavax Inc nvx-cov2373- nanoparticle-based prefusion, stable recombinant sars-cov-2 spike protein with novavax’ proprietary matrix-m as an adjuvant
Nvx Cov2373 Nanoparticle Based Prefusion, Stable Recombinant Sars Cov 2 Spike Protein With Novavax’ Proprietary Matrix M As An Adjuvant, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+adjuvant+matrix-m/nvx+cov2373/pmc07677683-191-27-22
Average 90 stars, based on 1 article reviews
nvx-cov2373- nanoparticle-based prefusion, stable recombinant sars-cov-2 spike protein with novavax’ proprietary matrix-m as an adjuvant - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Novavax Inc proprietary adjuvant matrix-m
Proprietary Adjuvant Matrix M, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proprietary+adjuvant+matrix-m/proprietary+adjuvant+matrix+m/pmc04514052-23-30-33
Average 90 stars, based on 1 article reviews
proprietary adjuvant matrix-m - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results